Achilles Therapeutics PLC: Achilles Therapeutics' New Immunogenicity Prediction Application of its AI-Powered PELEUS Platform Uniquely Identifies the Most Potent T Cell Antigens

- New AI module delivers a "Target-to-T cell" approach for revolutionizing the identification and prioritization of targets for personalized antigen approaches -LONDON, May 10, 2023 (GLOBE NEWSWIRE) --

Related Keywords

United Kingdom ,London ,City Of ,Melissa Gardiner ,Sukaina Virji ,Mary Jane Elliott ,Sergio Quezada ,Bioinformatics Data Science Team At Achilles ,Nasdaq ,Cancer Research United Kingdom ,National Institute Of Allergy ,Achille Material Acquisition Program ,Consilium Strategic Communications ,Target Tot Cell ,Chief Scientific Officer ,Data Science Team ,Operating Characteristic Area Under ,Immune Epitope Database ,National Institute ,Infection Disease ,Jane Elliott ,Gefallene Big Techs ,Achilles ,Herapeutics ,Immunogenicity ,Prediction ,Application ,Owered ,Seleus ,Platform ,Uniquely ,Dentifies ,Most ,Kpotent ,Fell ,Antigens ,